Cited by

• Invasive pneumococcal disease in children in Ireland--the anticipated benefit of conjugate pneumococcal vaccination.

  Fitzsimons JJ, Chong AL, Cafferkey MT, Butler KM. Fitzsimons JJ, et al. Ir J Med Sci. 2008 Sep;177(3):225-31. doi: 10.1007/s11845-008-0167-6. Epub 2008 Jun 27. Ir J Med Sci. 2008. PMID: 18584271
• Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation.

  Kimaro Mlacha SZ, Warira A, Gatakaa H, Goldblatt D, Scott JAG. Kimaro Mlacha SZ, et al. Sci Rep. 2018 Oct 18;8(1):15376. doi: 10.1038/s41598-018-33735-x. Sci Rep. 2018. PMID: 30337597 Free PMC article. Clinical Trial.
• Prevention of Pneumococcal Meningitis.

  Tan TQ. Tan TQ. Curr Infect Dis Rep. 2002 Aug;4(4):317-323. doi: 10.1007/s11908-002-0024-0. Curr Infect Dis Rep. 2002. PMID: 12126608
• Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection.

  Darkes MJ, Plosker GL. Darkes MJ, et al. Paediatr Drugs. 2002;4(9):609-30. doi: 10.2165/00128072-200204090-00005. Paediatr Drugs. 2002. PMID: 12175274 Review.
• Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein--conjugated pneumococcal vaccine in Filipino infants.

  Capeding MZ, Puumalainen T, Gepanayao CP, Käyhty H, Lucero MG, Nohynek H. Capeding MZ, et al. BMC Infect Dis. 2003 Aug 10;3:17. doi: 10.1186/1471-2334-3-17. BMC Infect Dis. 2003. PMID: 12908876 Free PMC article. Clinical Trial.